Verapamil Hcl

Form: Sustained-release tablets

Strength: 240 mg once daily

Reference Brands: Covera-HS®

Category: Drugs Using Osmotic Pump Systems

Covera-HS® (verapamil HCl) is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP and MDR standards. In the US, FDA approval involved clinical validation, safety assessments, and GMP compliance. In the EU, CE marking certifies conformity with MDR standards. These formulations undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring regulatory compliance guarantees access to high-quality verapamil formulations supporting cardiovascular disease management worldwide, ensuring safety, effectiveness, and optimal patient outcomes.